Interim report
Interim report January – March 2016
Continued growth
Net sales increased by 43% to 159.9 (111.4) MSEK
Operating income increased to 8.9 (3.8) MSEK
Net income increased to 8.3 (4.3) MSEK
Earnings per share increased to 0.40 (0.23) SEK
14 (9) EBM systems were delivered during the period
Order intake amounted to 6 (10) EBM systems
Continued growth
Arcam continues to grow and during the first quarter the increase in sales was 43%. Sales for the first quarter amounted to 159.9 (111.4) MSEK and trailing twelve months sales amounts to 624.6 (385.4) MSEK. Operating profit for the period amounts to 8.9 MSEK and trailing twelve months the operating profit is 55.3 MSEK.
The order intake during the period was 6 (10) EBM systems and the metal powder manufacturer AP&C doubled its order intake compared to the same period 2015.
We continue to pursue and develop our long-term strategy to industrialize the EBM technology and simultaneously developing the metal powder manufacturing and contract manufacturing business. We are making significant investments to continue to meet our customers’ demands and growing expectations of the EBM systems' productivity and reliability.
Business status
During the quarter we delivered 14 EBM systems and the majority went to customers in the implant or the aerospace industry. The demand for EBM systems is driven by the aerospace industry that is now moving into production, but also by the increasing interest for Additive Manufacturing from the orthopedic industry. In the period we received 6 new orders and the order book by the end of the quarter amounts to 19 systems.
We continue to expand our production capacity at AP&C to serve the fast growing market for metal powder for additive manufacturing. In the first quarter we took a decision to invest in three new powder reactors. With this expansion AP&C will reach a capacity of approximately 500 tons of metal powder per year.
The contract manufacturer DiSanto is growing again after a weak period at the later part of 2015. During the quarter we have added several new customers to the EBM part of the contract manufacturing.
A strengthened organization
During the quarter we strengthened our organization throughout the group.
In the beginning of January Alain Dupont assumed the position as president of the powder manufacturer AP&C. He succeeds Jacques Mallette who has been President of AP&C since 2011. Jacques continues to be involved as Chairman for AP&C.
In February Tom Barrett was appointed new president for our contract manufacturer DiSanto in the USA. Tom, who recently was Chief Commercial Officer (CCO) of Symmetry Medical, has a broad experience from leading positions within the implant industry.
With 19 machines in order, a stable aftermarket and a positive business situation we are positioned for a continued growth in 2016.
